HGHVX Mutual Fund

HGHVX Mutual Fund

NAV$52.60
See how much of HGHVX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 85 holdings · as of Apr 30, 2026
HGHVX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
12.11%		12.1%94,519$88.34MHealth CarePharmaceuticals
2
MRK
Merck & Co. Inc.Health Care · Pharmaceuticals
6.30%		18.4%421,010$45.97MHealth CarePharmaceuticals
Share changes, sector and industry · Pro
3
JNJ
Johnson & Johnson
5.81%		24.2%184,164$42.33M
4
UNH
Unitedhealth Group Inc.
5.54%		29.8%109,012$40.39M
5
ISRG
Intuitive Surgical Inc
3.62%		33.4%57,736$26.42M
6
ABBV
AbbVie Inc.
3.09%		36.5%106,556$22.52M
7
ABT
Abbott Laboratories
2.80%		39.3%224,493$20.38M
8
DHR
Danaher Corp.
2.68%		41.9%109,308$19.56M
9
EW
Edwards Lifesciences Corp
2.54%		44.5%222,047$18.54M
10
CVS
Cvs Health Corp.
2.44%		46.9%213,326$17.77M
11
VRTX
Vertex Pharmaceuticals Inc
2.40%		49.3%40,946$17.50M
12
BSX
Boston Scientific Corp.
2.32%		51.6%293,259$16.89M
13
ELV
Elevance Health Inc
2.06%		53.7%39,861$15.00M
14
COR
Cencora Inc
2.05%		55.8%48,572$14.96M
15
TMO
Thermo Fisher Scientific Inc
1.88%		57.6%28,548$13.67M
16
REGN
Regeneron Pharmaceuticals, Inc.
1.86%		59.5%19,182$13.56M
17
HCA
Hca Healthcare Inc.
1.80%		61.3%30,243$13.14M
18
BIIB
Biogen Inc.
1.34%		62.6%51,492$9.75M
19—GSK plc
1.30%		63.9%360,879$9.46M
20—Agilent Tech In 3.2 10/22
1.27%		65.2%79,872$9.23M
21
CAH
Cardinal Health Inc.
1.27%		66.5%47,856$9.23M
22
UTHR
United Therapeutics Corp
1.18%		67.7%15,097$8.63M
23
MDT
Medtronic Plc Ordinary Shares
1.18%		68.8%106,061$8.59M
24—Stryker Corp 3.375 11/25
1.17%		70.0%26,981$8.50M
25
DXCM
Dexcom Inc.
1.01%		71.0%123,198$7.34M
26—Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
0.90%		71.9%8,404$6.57M
27—Steris Ltd
0.85%		72.8%28,488$6.18M
28
INCY
Incyte Corp.
0.81%		73.6%61,927$5.90M
29
IONS
Ionis Pharmaceuticals Inc
0.81%		74.4%78,893$5.90M
30—Ucb Sa
0.79%		75.2%21,218$5.78M
31
ALNY
Alnylam Pharmaceuticals Inc.
0.77%		76.0%18,140$5.61M
32
BMY
Bristol-Myers Squibb Co.
0.73%		76.7%88,181$5.34M
33
MDGL
Madrigal Pharmaceuticals Inc
0.72%		77.4%10,120$5.24M
34
ASND
Ascendis Pharma A/S
0.72%		78.1%22,837$5.24M
35
ELAN
Elanco Animal Health Inc.
0.66%		78.8%215,158$4.81M
36
EHC
Encompass Health Corp
0.66%		79.4%47,796$4.78M
37
KLRA
Kailera Therapeutics Inc
0.65%		80.1%188,198$4.70M
38
HTFL
Heartflow, Inc.
0.60%		80.7%147,880$4.40M
39
GALD
Galderma Group Ag.
0.59%		81.3%20,401$4.28M
40
RCUS
Arcus Biosciences Inc
0.56%		81.8%160,316$4.09M
41—Icon Plc -
0.55%		82.4%33,670$3.98M
42
TECH
Bio-Techne Corp
0.55%		82.9%73,067$4.04M
43
CYTK
Cytokinetics Inc
0.55%		83.5%62,319$3.99M
44
PTGX
Protagonist Therapeutics Inc
0.55%		84.0%40,688$4.03M
45—Pharvaris N V Nv
0.53%		84.6%123,487$3.83M
46
AVTR
Avantor Inc
0.51%		85.1%461,799$3.74M
47
IRON
Disc Medicine, Inc.
0.51%		85.6%55,907$3.69M
48
MIRM
Mirum Pharmaceuticals Inc
0.51%		86.1%37,970$3.69M
49
VRDN
Viridian Therapeutics Inc
0.51%		86.6%278,409$3.75M
50
PTCT
Ptc Therapeutics Inc
0.47%		87.1%52,549$3.42M
More holdings · Pro
FundXLS Pro
See the other 35 holdings of HGHVX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

HGHVX Mutual Fund All Holdings

HGHVX holdings total 85 positions. The top 10 holdings account for 46.9% of the fund, led by Eli Lilly & Co. at 12.1%, Merck & Co. Inc. at 6.3%, Johnson & Johnson at 5.8%.

HGHVX portfolio concentration is moderate, with the top 10 representing 46.9% of total assets. The largest sector exposure is Health Care at 86.4%.

HGHVX sectors provide a detailed breakdown. HGHVX overlap shows how holdings compare to other funds in your portfolio.